Invitation to presentation of BioInvent’s interim report January–September 2021
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Kalender
| 2022-10-27 | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | Kvartalsrapport 2022-Q2 |
| 2022-07-12 | Extra Bolagsstämma 2022 |
| 2022-04-29 | Ordinarie utdelning BINV 0.00 SEK |
| 2022-04-28 | Årsstämma 2022 |
| 2022-04-27 | Kvartalsrapport 2022-Q1 |
| 2022-02-23 | Bokslutskommuniké 2021 |
| 2021-10-28 | Kvartalsrapport 2021-Q3 |
| 2021-08-26 | Kvartalsrapport 2021-Q2 |
| 2021-04-30 | Ordinarie utdelning BINV 0.00 SEK |
| 2021-04-29 | Årsstämma 2021 |
| 2021-04-28 | Kvartalsrapport 2021-Q1 |
| 2021-03-23 | Extra Bolagsstämma 2021 |
| 2021-02-23 | Bokslutskommuniké 2020 |
| 2020-12-14 | Split BINV 25:1 |
| 2020-11-27 | Extra Bolagsstämma 2020 |
| 2020-10-29 | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | Kvartalsrapport 2020-Q2 |
| 2020-05-29 | Ordinarie utdelning BINV 0.00 SEK |
| 2020-05-28 | Årsstämma 2020 |
| 2020-04-28 | Kvartalsrapport 2020-Q1 |
| 2020-02-27 | Bokslutskommuniké 2019 |
| 2019-10-24 | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | Kvartalsrapport 2019-Q2 |
| 2019-04-26 | Ordinarie utdelning BINV 0.00 SEK |
| 2019-04-25 | Årsstämma 2019 |
| 2019-04-25 | Kvartalsrapport 2019-Q1 |
| 2019-03-20 | Extra Bolagsstämma 2019 |
| 2019-02-25 | Bokslutskommuniké 2018 |
| 2018-10-24 | Kvartalsrapport 2018-Q3 |
| 2018-07-24 | Kvartalsrapport 2018-Q2 |
| 2018-04-25 | Ordinarie utdelning BINV 0.00 SEK |
| 2018-04-24 | Kvartalsrapport 2018-Q1 |
| 2018-04-24 | Årsstämma 2018 |
| 2018-01-30 | Bokslutskommuniké 2017 |
| 2017-10-26 | Kvartalsrapport 2017-Q3 |
| 2017-07-26 | Kvartalsrapport 2017-Q2 |
| 2017-05-18 | Ordinarie utdelning BINV 0.00 SEK |
| 2017-05-17 | Årsstämma 2017 |
| 2017-05-17 | Kvartalsrapport 2017-Q1 |
| 2017-02-15 | Bokslutskommuniké 2016 |
| 2017-01-24 | Extra Bolagsstämma 2017 |
| 2016-10-25 | Kvartalsrapport 2016-Q3 |
| 2016-07-26 | Kvartalsrapport 2016-Q2 |
| 2016-05-13 | Ordinarie utdelning BINV 0.00 SEK |
| 2016-05-12 | Årsstämma 2016 |
| 2016-04-26 | Kvartalsrapport 2016-Q1 |
| 2016-03-18 | Extra Bolagsstämma 2016 |
| 2016-02-17 | Bokslutskommuniké 2015 |
| 2015-10-22 | Kvartalsrapport 2015-Q3 |
| 2015-07-22 | Kvartalsrapport 2015-Q2 |
| 2015-04-23 | Ordinarie utdelning BINV 0.00 SEK |
| 2015-04-22 | Årsstämma 2015 |
| 2015-04-22 | Kvartalsrapport 2015-Q1 |
| 2015-02-18 | Bokslutskommuniké 2014 |
| 2014-10-23 | Kvartalsrapport 2014-Q3 |
| 2014-07-24 | Kvartalsrapport 2014-Q2 |
| 2014-05-06 | Kvartalsrapport 2014-Q1 |
| 2014-04-25 | Ordinarie utdelning BINV 0.00 SEK |
| 2014-04-24 | Årsstämma 2014 |
| 2014-03-19 | Extra Bolagsstämma 2014 |
| 2014-02-20 | Bokslutskommuniké 2013 |
| 2013-10-24 | Kvartalsrapport 2013-Q3 |
| 2013-07-25 | Kvartalsrapport 2013-Q2 |
| 2013-06-19 | Extra Bolagsstämma 2013 |
| 2013-04-26 | Ordinarie utdelning BINV 0.00 SEK |
| 2013-04-25 | Årsstämma 2013 |
| 2013-04-25 | Kvartalsrapport 2013-Q1 |
| 2013-02-21 | Bokslutskommuniké 2012 |
| 2012-10-18 | Kvartalsrapport 2012-Q3 |
| 2012-09-28 | Kapitalmarknadsdag 2012 |
| 2012-07-19 | Kvartalsrapport 2012-Q2 |
| 2012-04-19 | Kvartalsrapport 2012-Q1 |
| 2012-03-27 | Ordinarie utdelning BINV 0.00 SEK |
| 2012-03-26 | Årsstämma 2012 |
| 2012-03-09 | Extra Bolagsstämma 2012 |
| 2012-02-09 | Bokslutskommuniké 2011 |
| 2011-11-08 | Kapitalmarknadsdag 2011 |
| 2011-10-13 | Kvartalsrapport 2011-Q3 |
| 2011-07-14 | Kvartalsrapport 2011-Q2 |
| 2011-04-14 | Kvartalsrapport 2011-Q1 |
| 2011-03-25 | Ordinarie utdelning BINV 0.00 SEK |
| 2011-03-24 | Årsstämma 2011 |
| 2011-02-10 | Bokslutskommuniké 2010 |
| 2010-10-14 | Kvartalsrapport 2010-Q3 |
| 2010-07-14 | Kvartalsrapport 2010-Q2 |
| 2010-04-21 | Ordinarie utdelning BINV 0.00 SEK |
| 2010-04-20 | Årsstämma 2010 |
| 2010-04-15 | Kvartalsrapport 2010-Q1 |
| 2010-02-17 | Bokslutskommuniké 2009 |
| 2009-10-15 | Kvartalsrapport 2009-Q3 |
| 2009-07-15 | Kvartalsrapport 2009-Q2 |
| 2009-04-22 | Ordinarie utdelning BINV 0.00 SEK |
| 2009-04-21 | Årsstämma 1 |
| 2009-04-16 | Kvartalsrapport 2009-Q1 |
Lund, Sweden, October 28, 2021 – BioInvent International AB (Nasdaq Stockholm: BINV) invites to a presentation of the third quarter report 2021 and a telephone conference with CEO Martin Welschof. The presentation will be held in English.
When: 2:00 p.m. CEST Thursday October 28, 2021.
Listen to the presentation: https://tv.streamfabriken.com/bioinvent-q3-2021
To participate in the telephone conference, please use the dial-in details shown below:
SE: +46850558355
NE: +31107129163
UK: +443333009274
US: +16467224903
The conference call will be made available on the company’s website after the call.
Contacts
Cecilia Hofvander
Senior Director Investor Relations
Tel: +46 46 286 85 50
Email. cecilia.hofvander@bioinvent.com
About Us
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The Company’s validated, proprietary F.I.R.S.T™ technology platform simultaneously identifies both targets and the antibodies that bind to them, generating many promising new drug candidates to fuel the Company’s own clinical development pipeline or for additional licensing and partnering.
The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company’s fully integrated manufacturing unit. More information is available at www.bioinvent.com. Follow us on Twitter: @BioInvent.